Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	0.62	66.46	66.05
Graham Fair Price	11.11	13.69	12.32
PEG	0.39	0.34	-0.34
Price/Book	8.91	1.09	1.00
Price/Cash Flow	20.68	18.89	15.66
Prices/Earnings	-10.77	7.54	8.45
Price/Sales	89.17	29.70	15.70
Price/FCF	20.68	18.89	15.66
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	120.40	1.70	0.77
Operating Margin	77.97	0.92	0.51
ROA	18.42	0.02	0.01
ROE	0.03	0.04	22.05
ROIC	0.01	0.01	0.27
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	0.07	-0.02	291.26
Dividends QOQ	0.06	0.06	-1.55
EBIT QOQ	-0.18	0.04	-80.24
EPS QOQ	-0.25	0.22	-11.11
FCF QOQ	1.55	-0.09	-94.39
Revenue QOQ	0.50	-0.42	-15.87
Naive Interpretation	member

03 - Financial Growth · Bad

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	547.20	-709.09	29.59
Days Sales Outstanding (DSO)	30.06	62.32	107.35
Inventory Turnover	0.16	-0.13	-22.83
Debt/Capitalization	0.58	0.59	1.81
Quick Ratio	3.46	6.71	93.83
Naive Interpretation	member

04 - Leverage & Liquidity · Balanced

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	15.11	15.20	0.57
Cash	0.40	1.68	323.43
Capex	0.00	0.00	0.00
Free Cash Flow	0.96	0.88	-9.23
Revenue	0.96	0.56	-42.10
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	6.30	9.78	55.20
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	35.56	34.05	-4.24
Naive Interpretation	Member

06 - Financial Health · Bad

Rating